Arkolith/Insider Trading/SYRE/Form 4

Turtle Cameron

Chief Executive Officer, DirectorSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$740K
Net Open-Market Flow
-$740K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Sell(S)12K$49.20$607K630K
Apr 1, 2026Sell(S)3K$49.92$133K628K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001758363-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML